Search Results
Search Results For
Medisafe is pleased to share the latest results from a University of Sydney study, showing that mobile apps can have a significant impact on those living with coronary heart disease. Following an initial study conducted in 2016 to identify the leading medication management platform, in which Medisafe was found to be the top performing solution,…
Read More
Lorna Weir from Elevate Healthcare Marketing, Stacey Meltzer Wasserman from Medisafe®, as well as KJT’s Katy Palmer, PhD and Ellen Gordon discuss bridging the worlds between insights, advertising, digital solutions, advocacy, and more.Among the covered topics: – The importance of representing and elevating the patient voice – Solutions to overcome the unique hurdles of the…
Read More
MIAMI — June 7, 2018 — Medisafe, the leading medication management platform with almost four and a half million registered users, today released data showing that previously non-adherent HIV patients increase their prescription refills after they start using the company’s mobile app. These results are part of a landmark study conducted by IQVIA, a leading global provider…
Read More
Want to keep current on the FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS)? Follow the LinkedIn profiles of these professionals at the forefront of integrating digital health solutions with pharmaceutical products affected by PDURS. PDURS: The Agency Perspective Martin Culjat, PhD, Eversana – Martin Culjat is the Senior Vice President and Global…
Read More
The FDA’s draft guidelines for Prescription Drug Use Related Software (PDURS) have drawn significant attention from the legal community. Law firms and legal experts have provided detailed analyses and comments, focusing on the potential implications for pharmaceutical companies and digital health innovators. Here is a summary of five notable responses from law firms or lawyers…
Read More
The FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS) have sparked considerable discussion among various stakeholders, including pharmaceutical companies, healthcare organizations, and digital health advocates. While praising and supporting the FDA’s work to issue clear guidance, most also had specific requests for additional clarity, especially about clinical trial requirements for digital health software…
Read More
The FDA’s new Draft Guidelines for Prescription Drug Use Related Software (PDURS) are shaping the future of digital health in the pharmaceutical industry. These guidelines aim to ensure the safety and efficacy of software that supports prescription drug use, marking a pivotal moment for digital health professionals. As executives at the forefront of pharmaceutical digital…
Read More
As the digital health landscape evolves, pharmaceutical companies must adapt to new regulatory frameworks that ensure patient safety and product efficacy. The FDA’s Draft Guidelines for Prescription Drug Use Related Software (PDURS) mark a significant step in this direction, providing comprehensive standards for software intended to support prescription drug use. For pharmaceutical brand marketers and…
Read More
In an era where digital health tools are becoming increasingly integrated into healthcare delivery, regulatory frameworks must adapt to ensure these innovations are safe, effective, and beneficial to patients. The FDA’s Prescription Drug Use Related Software (PDURS) guidance is a significant step in this direction. This guidance focuses on software intended to support the use…
Read More
Medisafe, the leading medication management platform with over four million registered users, announced today the first wave of results from a novel study, which among other objectives, measures the accuracy of self-reported outcomes (SROs). Medisafe’s study was conducted in partnership with the leading global provider of information, innovative technology solutions and contract research services focused…
Read More